AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-71 Cr | ₹-76 Cr | ₹-26 Cr | ₹0.95 Cr | ₹46 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AJANTA PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-71 Cr |
| Mar2025 | ₹-76 Cr |
| Mar2024 | ₹-26 Cr |
| Mar2023 | ₹0.95 Cr |
| Mar2022 | ₹46 Cr |
How is Deferred Tax Assets / Liabilities of AJANTA PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-71 Cr | Negative | |
| Mar2025 | ₹-76 Cr | Negative | |
| Mar2024 | ₹-26 Cr | Negative | |
| Mar2023 | ₹0.95 Cr | -97.95 | |
| Mar2022 | ₹46 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹44,249.4 Cr | 0.8% | -2.1% | 35.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 0.8% |
-2.1% |
35.9% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses